vaccine
No description yet: the sentence for this tag has not been written. 4 records carry it: 4 people.
4 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Catherine J. Wu Chief, Division of Stem Cell Transplantation and Cellular Therapies, Dana-Farber Cancer Institute; Professor, Harvard Medical School · Dana-Farber Brigham Cancer Center Led the first personalised neoantigen peptide vaccine trial in melanoma and mapped how CLL evolves under treatment. | Melanoma, Chronic lymphocytic leukaemia, Glioma & glioblastoma | none | neoantigen, genomics | ||
Jeffrey S. Weber Deputy Director, NYU Langone Perlmutter Cancer Center; Professor of Medicine · Laura and Isaac Perlmutter Cancer Center at NYU Langone Health Led CheckMate 238, which made adjuvant nivolumab standard after melanoma surgery, and co-led the mRNA vaccine trial KEYNOTE-942. | Melanoma | none | melanoma, adjuvant | ||
Uğur Şahin Professor of Translational Oncology, University Medical Center Mainz; Co-founder and CEO, BioNTech · University Cancer Center Mainz (UCT Mainz) / Universitätsmedizin Mainz Immunologist who built individualised mRNA neoantigen vaccines for cancer, the platform later used for COVID-19. | Melanoma, Pancreatic ductal adenocarcinoma | none | mrna, immunotherapy | ||
Vinod P. Balachandran Surgical Oncologist and Member, Immuno-Oncology Service, Memorial Sloan Kettering Cancer Center · Memorial Sloan Kettering Cancer Center Surgeon-scientist whose personalised mRNA vaccine trial showed pancreatic cancer can provoke lasting T-cell immunity. | Pancreatic ductal adenocarcinoma | none | pancreatic, immunotherapy |
